Clinical Trial Update: CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12 [Phase 2]

View source ↗

Summary

Phase 2 trial update for CINRYZE in children under 12 with hereditary angioedema has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Cinryze (C1 esterase inhibitor)

Snippet

Sponsor: Shire | Conditions: Hereditary Angioedema (HAE) | Phase 2 | Status: COMPLETED | Results posted: 2014-07-25